许英铭.复方阿嗪米特、伊托必利及黛力新合用治疗功能性消化不良的临床有效性综合评价[J].内科急危重症杂志,2016,22(3):
扫码阅读全文
|
| DOI： |
| 中文关键词: 功能性消化不良 黛力新 复方阿嗪米特 伊托必利 |
| 英文关键词:functional dyspepsia Deanxit azintamide itopride |
| 基金项目: |
|
| 摘要点击次数: 2721 |
| 全文下载次数: 3847 |
| 中文摘要: |
| 目的：探讨对功能性消化不良(FD)患者采用复方阿嗪米特、伊托必利联合黛力新治疗的临床效果。方法：随机选取FD患者80例，随机分为三联组与二联组，各40例；二联组采用复方阿嗪米特、伊托必利二联方案治疗；三联组在二联组的基础上联合黛力新治疗。结果：三联组的总有效率为97.50%，显著高于二联组的80.00%；三联组治疗后的SDS评分、SAS 评分分别为(44.60±4.27)分、(45.27±2.63)分，均显著低于二联组的(52.37±4.68)分、(53.32±3.18)分；三联组的平均胃半排空时间、胃排空时间分别为(27.58±3.28)min、(39.60±4.45)min，均显著短于二联组的(39.37±4.36)min、(51.28±5.61)min；有统计学意义(P < 0. 05)。结论：对FD患者采用复方阿嗪米特、伊托必利、黛力新联合治疗，能有效改善患者的临床症状及心理情绪，疗效显著，且不会明显增加不良反应，值得推广。 |
| 英文摘要: |
| Objective: To investigate the functional dyspepsia (FD) patients with azintamide clinical results itopride joint Deanxit treatment. Methods: 80 patients were randomly selected FD were randomly divided into groups with two triple-linked group, the 40 cases; bivalent group with azintamide, itopride bivalent regimen; triple group basis bivalent group joint Deanxit treatment. Results: The total effective rate of triplets 97.50%, significantly higher than 80.00% bivalent group; triple therapy group after the SDS score, SAS scores were (44.60 ± 4.27) points, (45.27 ± 2.63) points, were significantly lower than the bivalent group (52.37 ± 4.68) points, (53.32 ± 3.18) points; the average gastric emptying half-time triple group, gastric emptying time was (27.58 ± 3.28) min, (39.60 ± 4.45) min, were significantly shorter than the bivalent group (39.37 ± 4.36) min, (51.28 ± 5.61) min; statistically significant (P <0. 05). Conclusion: FD patients with azintamide, itopride, Deanxit combination therapy, can effectively improve the clinical symptoms and the patient's psychological and emotional, a significant effect, and will not significantly increase the adverse reactions, it is worth promoting. |
|
|
|
|
